The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04675892
Recruitment Status : Recruiting
First Posted : December 19, 2020
Last Update Posted : February 20, 2024
Sponsor:
Information provided by (Responsible Party):
Thierry Christen, Centre Hospitalier Universitaire Vaudois

Brief Summary:
The purpose of this study is to compare the effectiveness of resection of one or both slips of the flexor digitorum superficialis tendon versus the A1 pulley division.

Condition or disease Intervention/treatment Phase
Trigger Finger Stenosing Tenosynovitis Procedure: A1 pulley division Procedure: A1 pulley division + Resection of one or both slips of the FDS tendon Not Applicable

Detailed Description:

The preoperative visit occurred a number of weeks or months prior to surgery. Surgeons from the Centre de la main at the CHUV in Lausanne recruited the subjects during their consultations. During this initial visit, the patient was asked about his problem, his general health and a clinical examination (including range of motion of finger joints, pulp-to-palm distance, pain evaluated with a VAS) was performed. Once the diagnosis of trigger finger was established, the inclusion and exclusion criteria were evaluated. If the eligibility criteria were fulfilled, the patients were offered to be part of the study. They received oral and written information about the study and the surgeons gave further explanation if needed.

On the surgery day, the signed consent form was recovered. Participants were randomized in two groups according to a computer-generated list ranging from 01 to 60 (www.randomization.com). Surgery was then performed according to the method chosen by randomization. The possible occurrence of adverse effects during surgery was monitored. All information was recorded on the case report forms.

The first postoperative visit occurred 1 week ± 3 days after surgery. The surgeons evaluated the wound to exclude the presence of postoperative complication (infection, hematoma, nerve or tendon injury) and answer any question the patient could have. Range of motion and pain were recorded. All information was recorded on the case report forms.

The second postoperative visit occurred 4 weeks ± 5 days after surgery. The appointment was conducted in the same way as the previous one.

Patients could choose to be withdrawn from the study at any point. The follow-up was similar to that of patients included in the study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Masking Description: Participants were randomized in two groups according to a computer-generated list ranging from 01 to 60 (www.randomization.com). Surgery was then performed according to the method chosen by randomization.
Primary Purpose: Treatment
Official Title: Resection of One or Both Slips of the Flexor Digitorum Superficialis Tendon for Cases of Severe Trigger Fingers. A Randomized Prospective Single Center Study
Actual Study Start Date : November 1, 2018
Estimated Primary Completion Date : November 1, 2024
Estimated Study Completion Date : December 1, 2024

Arm Intervention/treatment
Active Comparator: A1 pulley group
A1 pulley division only
Procedure: A1 pulley division

Local anesthesia with 5-10 ml of solution required (90 % lidocaine 1 % with 1 ug epinephrine, 10 % sodium bicarbonate 8.4 %).

Division of the A1 pulley.

Wound closure with absorbable sutures and application of a light dressing.


Experimental: A1 pulley + FDS group
Combination of A1 pulley division and excision of one or both slips of the flexor digitorum superficialis tendon
Procedure: A1 pulley division + Resection of one or both slips of the FDS tendon

Local anesthesia with 5-10 ml of solution required (90 % lidocaine 1 % with 1 ug epinephrine, 10 % sodium bicarbonate 8.4 %).

Division of the A1 pulley.

Palmar Bruner incision over the PIP joint. Distal dissection and resection of one or both slips of the FDS tendon.

Wound closure with absorbable sutures and application of a light dressing.





Primary Outcome Measures :
  1. Change in total active finger motion in degrees [ Time Frame: Preoperative (days to weeks prior to surgery), 4 weeks after surgery ]
    Change in preoperative and postoperative overall range of motion of the finger joints in degrees


Secondary Outcome Measures :
  1. Change in with the visual analog scale [ Time Frame: Preoperative (days to weeks prior to surgery), 4 weeks after surgery ]
    Change in pain with the visual analog scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients (≥18 years old) with a flexor tendon tenosynovitis of a finger resulting in a decreased range of motion of the PIP joint (defined with a palm-to-pulp distance ≥0mm and/or flexion contracture ≥15°).

Exclusion Criteria:

  • Minors (<18 years old).
  • PIP joint contracture resulting from another illness than stenosing flexor tenosynovitis (for example: rheumatoid arthritis) or caused by a traumatic event.
  • Contraindications to any surgery: presence of a severe coagulation disorder, immunosuppression or decompensated psychiatric illness.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04675892


Contacts
Layout table for location contacts
Contact: Thierry Christen, MD +41(0)795561287 thierry.christen@chuv.ch

Locations
Layout table for location information
Switzerland
CHUV Recruiting
Lausanne, VD, Switzerland, 1011
Contact: Thierry Christen, MD    +41(0)795561287    thierry.christen@chuv.ch   
Sponsors and Collaborators
Centre Hospitalier Universitaire Vaudois
Layout table for additonal information
Responsible Party: Thierry Christen, Principal investigator, Centre Hospitalier Universitaire Vaudois
ClinicalTrials.gov Identifier: NCT04675892    
Other Study ID Numbers: 2018-01270
First Posted: December 19, 2020    Key Record Dates
Last Update Posted: February 20, 2024
Last Verified: February 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Thierry Christen, Centre Hospitalier Universitaire Vaudois:
trigger finger
stenosing flexor tenosynovitis
Additional relevant MeSH terms:
Layout table for MeSH terms
Trigger Finger Disorder
Tenosynovitis
Tendon Entrapment
Tendinopathy
Muscular Diseases
Musculoskeletal Diseases